A Single-Blinded Prospective Study on Using Botulinum Toxin Type A for Reducing Alar Mobility

Area of Science:

• Plastic Surgery
• Dermatology
• Aesthetic Medicine

Background:

• Growing demand for minimally invasive cosmetic procedures to enhance facial aesthetics.
• Limited practical treatments available for reducing dynamic nasal alar mobility.

Purpose of the Study:

• To evaluate the efficacy of botulinum toxin type A in reducing nasal alar mobility.
• To assess botulinum toxin as a supplemental treatment option for rhinoplasty.

Main Methods:

• A single-blind prospective study involving 20 participants.
• Injection of 3U botulinum toxin type A into specific nasal muscles in the experimental group.
• Measurement of alar mobility using a 3D imaging system before and after treatment, comparing to a saline control group.

Main Results:

• Significant reduction in alar flaring and base mobility in the botulinum toxin group (P < 0.05).
• No significant changes in alar mobility observed in the control group.
• Root mean square analysis indicated significantly greater changes in the experimental group compared to the control (P < 0.05).

Conclusions:

• Botulinum toxin type A is effective in reducing alar mobility.
• The treatment offers a safe, minimally invasive option for improving dynamic alar aesthetics.
• Botulinum toxin can be a valuable supplemental treatment in rhinoplasty procedures.